Compare CYPH & MLCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CYPH | MLCI |
|---|---|---|
| Founded | 2011 | N/A |
| Country | United States | United States |
| Employees | 6 | 21 |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.4M | 69.6M |
| IPO Year | N/A | N/A |
| Metric | CYPH | MLCI |
|---|---|---|
| Price | $0.99 | $4.35 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.5M | 22.9K |
| Earning Date | 05-13-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 2.63% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.50 | $3.31 |
| 52 Week High | $3.70 | $8.68 |
| Indicator | CYPH | MLCI |
|---|---|---|
| Relative Strength Index (RSI) | 60.96 | 49.95 |
| Support Level | $0.94 | $3.31 |
| Resistance Level | $1.01 | $7.98 |
| Average True Range (ATR) | 0.10 | 0.25 |
| MACD | 0.00 | 0.07 |
| Stochastic Oscillator | 66.66 | 42.31 |
Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.
Mount Logan Capital Inc operates as emerging asset management and investment firm focused on investing in public and private debt securities in the North American market. The Company's reporting segments include asset management and insurance. The asset management segment reflects the Company's historical operations through its subsidiaries, including ML Management, and the insurance segment represents Ability's operations. The Company through its subsidiaries, earns management and incentive fees and servicing fees for providing investment management, monitoring and other services to investment vehicles and advisers. The insurance business is operated by Ability. Ability's insurance business consists of premium revenue from long term care insurance policies.